SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001193125-20-250299
Filing Date
2020-09-21
Accepted
2020-09-21 17:26:22
Documents
15

Document Format Files

Seq Description Document Type Size
1 F-3 d19008df3.htm F-3 634388
2 EX-1.2 d19008dex12.htm EX-1.2 213414
3 EX-4.1 d19008dex41.htm EX-4.1 104957
4 EX-4.2 d19008dex42.htm EX-4.2 304971
5 EX-5.1 d19008dex51.htm EX-5.1 12654
6 EX-5.2 d19008dex52.htm EX-5.2 11689
7 EX-23.1 d19008dex231.htm EX-23.1 6748
8 GRAPHIC g19008dsp0034.jpg GRAPHIC 2825
9 GRAPHIC g19008g02q02.jpg GRAPHIC 133332
10 GRAPHIC g19008g0711082631486.jpg GRAPHIC 3044
11 GRAPHIC g19008g14w32.jpg GRAPHIC 33233
12 GRAPHIC g19008g42a76.jpg GRAPHIC 24406
13 GRAPHIC g19008g72x74.jpg GRAPHIC 3502
14 GRAPHIC g68491g02q02.jpg GRAPHIC 133332
15 GRAPHIC g68491g45d84.jpg GRAPHIC 34924
  Complete submission text file 0001193125-20-250299.txt   1798473
Mailing Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008
Business Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008 011-33-4-78-74-44-38
Erytech Pharma S.A. (Filer) CIK: 0001624422 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-248953 | Film No.: 201187253
SIC: 2836 Biological Products, (No Diagnostic Substances)